| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/14/2009 | CN101342143A Preparation of antineoplastic drug docetaxel injection |
| 01/14/2009 | CN101342142A Temperature sensing in situ gel rubber formulations capable of being injected, preparation method and uses thereof |
| 01/14/2009 | CN100451109C Recombinant herpes simplex virus type 2 and its preparing method and use |
| 01/14/2009 | CN100451033C Gene for inhibiting human transcription factor AP-1, its encoding polypeptide and uses |
| 01/14/2009 | CN100451032C Oyster low molecular active peptide and its preparation method and application in the preparation of anticancer medicine |
| 01/14/2009 | CN100450553C Degradable radioactive sponge and its making process |
| 01/14/2009 | CN100450545C Application of musculus growth inhibin for preparing anticarcinogen |
| 01/14/2009 | CN100450490C Use of caudatin-3-O-beta-D-cymaroside as medicament for treating tumour |
| 01/14/2009 | CN100450487C Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation |
| 01/14/2009 | CN100450486C Application of dipyridamole in preparation of anti-malignant tumor medicine |
| 01/14/2009 | CN100450477C Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 01/13/2009 | US7476744 Polymorphic crystalline forms of celecoxib |
| 01/13/2009 | US7476743 Treating cellular proliferation disease with 1,2,5-triazol-5-one and as an anticancer agent and inhibitor of kinesins for treatment of hyperplasia or restenosis |
| 01/13/2009 | US7476721 Modified cytokines for use in cancer therapy |
| 01/13/2009 | US7476720 Rat neurotrophic factor receptor, GFR α-4 |
| 01/13/2009 | US7476719 Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof |
| 01/13/2009 | US7476692 useful for the treatment of cancer and other hyperproliferative disorders; a sphingolipid; lactic acid; and optionally a stabilizing agent; emulsion |
| 01/13/2009 | US7476691 Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors |
| 01/13/2009 | US7476688 Cyclic amidine derivatives |
| 01/13/2009 | US7476683 Glycinamide derivatives as raf-kinase inhibitors |
| 01/13/2009 | US7476680 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
| 01/13/2009 | US7476670 anticancer/antiproliferative activity; antifungal agents; protein kinases inhibitors in perticular Focal Adhesion Kinase inhibitors and fungal CIV1 protein kinase inhibitors; N-[6-(5,6-dichloro-2,3-dihydro-1H-indol-1-yl)-9H-purin-2-yl]-1,4-cyclohexanediamine dihydrochloride |
| 01/13/2009 | US7476669 Immobilization of taxane; anticancer, antitumor agents |
| 01/13/2009 | US7476661 for treating basal cell carcinomas, medulloblastomas, and tumors |
| 01/13/2009 | US7476657 Appear to function at least in part by inhibiting G2 cell cycle checkpoint; useful in treating metastatic and non-metastatic solid or liquid tumors |
| 01/13/2009 | US7476649 Antiproliferative and antiviral proteins and peptides |
| 01/13/2009 | US7476509 Compounds and methods for modulating functions of nonclassical cadherins |
| 01/13/2009 | US7476389 Papillomavirus vaccines |
| 01/13/2009 | US7476382 Reovirus for the treatment of neoplasia |
| 01/13/2009 | US7476380 Using vitamin A and/or the derivatives and/or the esters for therapy and prophylaxis, side effect reduction |
| 01/13/2009 | CA2423280C Inhibitors of cyclic guanosine 3', 5'-monophosphates specific phosphodiesterase |
| 01/13/2009 | CA2392902C Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 01/13/2009 | CA2390631C Carboxamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 01/13/2009 | CA2386772C Pentacyclic taxane compound |
| 01/13/2009 | CA2369626C Use of cell membrane penetrating indigoid bisindole derivatives |
| 01/13/2009 | CA2304704C Formulations and methods for reducing toxicity of antineoplastic agents |
| 01/13/2009 | CA2301032C A method of preventing or treating estrogen-dependent diseases and disorders |
| 01/13/2009 | CA2293372C Benzo(5,6)cyclohepta(1,2b)pyridine derivatives useful for inhibition of farnesyl protein transferase |
| 01/13/2009 | CA2263750C Use of a melanoma differentiation associated gene (mda-7) for reversing a cancerous phenotype |
| 01/08/2009 | WO2009006569A1 Pyrimidyl cyclopentanes as akt protein kinase inhibitors |
| 01/08/2009 | WO2009006541A2 Proteinases destroy cancer tumor's solid structure and kill cancer cells locally |
| 01/08/2009 | WO2009006404A2 Heterocyclic compounds useful as raf kinase inhibitors |
| 01/08/2009 | WO2009006389A2 Pyrimidine derivatives useful as raf kinase inhibitors |
| 01/08/2009 | WO2009006046A1 Dendrimer conjugates of agonists and antagonists of the gpcr superfamily |
| 01/08/2009 | WO2009006043A2 Potentiation of cancer chemotherapy by 7-(2,5-dihydro-4-imidazo [1,2-a]pyrine-3-yl-2,5-dioxo-ih-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro-2-(1-piperidinyl-carbonyd-pyrrolo[3,2,1-jk][1,4]benzodiazepine |
| 01/08/2009 | WO2009005839A2 Conjugates of compounds binding the steroid hormone receptor and their use as anticancer drugs |
| 01/08/2009 | WO2009005172A1 Pharmaceutical combination of nsaid and prostaglandin compound |
| 01/08/2009 | WO2009005142A1 Method for diagnosis of malignancy of gastrointestinal stromal tumor whose primary lesion is in stomach |
| 01/08/2009 | WO2009005123A1 INTERFERON-β PRODUCTION PROMOTER, AND METHOD FOR PRODUCTION THEREOF |
| 01/08/2009 | WO2009005045A1 Substituted dihydroisoquinoline derivative |
| 01/08/2009 | WO2009004995A1 Method of fixing and expressing physiologically active substance |
| 01/08/2009 | WO2009004822A1 ANTI-Muc17 ANTIBODY |
| 01/08/2009 | WO2009004798A1 Therapeutic agent and therapeutic method for mesothelioma |
| 01/08/2009 | WO2009004356A1 Phthalazinone derivatives as inhibitors of parp-1 |
| 01/08/2009 | WO2009004329A1 9h-pyrimido[4,5-b]indoles, 9h-pyrido[4',3':4,5]pyrrolo[2,3-d]pyridines, and 9h-1,3,6,9-tetraaza-fluorenes as chk1 kinase function inhibitors |
| 01/08/2009 | WO2009004152A2 Use of a composition of oligomers of galacturonic acid as an agent for inhibiting degradation of collagen |
| 01/08/2009 | WO2009004146A2 Novel herbimycin a analogue derivatives, compositions containing same and use thereof |
| 01/08/2009 | WO2009004060A1 Novel triazine compounds for treatment of cancer |
| 01/08/2009 | WO2009003999A2 Chemical compounds |
| 01/08/2009 | WO2009003911A1 Thiophene-imidazopyridines |
| 01/08/2009 | WO2009003669A2 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment |
| 01/08/2009 | WO2009003625A1 Aminophenoxazinone as an anti-tumour and anti-inflammatory agent |
| 01/08/2009 | WO2009003489A1 CaOU-1 EPITOPE BINDING POLYPEPTIDES |
| 01/08/2009 | WO2008142720A3 Quinazolin-oxime derivatives as hsp90 inhibitors |
| 01/08/2009 | WO2008134474A3 Compositions and methods including cell death inducers and procaspase activation |
| 01/08/2009 | WO2008128009A3 Aminopyrimidines useful as kinase inhibitors |
| 01/08/2009 | WO2008120202A3 Antibodies, methods and kits for diagnosing and treating melanoma |
| 01/08/2009 | WO2008120098A3 Peptide prodrugs |
| 01/08/2009 | WO2008119567A3 Cross-species-specific cd3-epsilon binding domain |
| 01/08/2009 | WO2008119565A3 Cross-species-specific binding domain |
| 01/08/2009 | WO2008109005A3 Use of anti-cd22 immunotoxins and protein-synthesis-inhibiting chemotherapeutic agents in treatment of b cell cancers |
| 01/08/2009 | WO2008107471A3 Modified hydroxypolymer conjugates with killing effect on tumor cells |
| 01/08/2009 | WO2008089389A3 Treatment of cancers with acquired resistance to kit inhibitors |
| 01/08/2009 | WO2008084087A3 Dbait and its standalone uses thereof |
| 01/08/2009 | WO2008080001A3 Compounds and methods for kinase modulation, and indications therefor |
| 01/08/2009 | WO2008073509A3 Compositions and methods for treating a neoplasm |
| 01/08/2009 | WO2008063548A3 5, 6, or 7-substituted-s- (hetero)arylisoquinolinamine derivatives as antitumor agents |
| 01/08/2009 | WO2007143098A8 Hepatocyte growth factor (hgf) binding proteins |
| 01/08/2009 | WO2007118198A8 2-METHYLENE-1α,25-DIHYDROXY-19,21-DINORVITAMIN D3 ANALOGS AND USES THEREOF |
| 01/08/2009 | WO2007087026A9 Solid-state form of amg 706 and pharmaceutical compositions thereof |
| 01/08/2009 | US20090013420 Psmcs as Modifiers of the Rb Pathway and Methods of Use |
| 01/08/2009 | US20090012175 Methods of treating cancer with HDAC inhibitors |
| 01/08/2009 | US20090012149 Prodrug of an ice inhibitor |
| 01/08/2009 | US20090012130 Strategies for Designing Drugs that Target the Sir2 Family of Enzymes |
| 01/08/2009 | US20090012129 Novel biaromatic compounds that modulate ppar-receptors |
| 01/08/2009 | US20090012124 4-(2,6-dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide acid addition salts as kinase inhibitors |
| 01/08/2009 | US20090012122 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/08/2009 | US20090012120 Synthesis of N-heterocycles, beta-amino acids, and allyl amines via aza-payne mediated reaction of ylides and hydroxy aziridines |
| 01/08/2009 | US20090012114 Cyclohepta[B]Pyridine-3-Carbonylguanidine Derivative and Pharmaceutical Product Containing Same |
| 01/08/2009 | US20090012111 Crystalline polymorph of 7-ethyl-10-hydroxycamptothecin |
| 01/08/2009 | US20090012109 Cyclopamine analogs |
| 01/08/2009 | US20090012104 Inhibitors of 5'-Methylthioadenosine Phosphorylase and 5'-Methylthioadenosine/S-Adenosylhomocysteine Nucleosidase |
| 01/08/2009 | US20090012102 Imidazo[1,2-C]Pyrimidinylacetic Acid Derivatives |
| 01/08/2009 | US20090012093 Receptor Function Regulator |
| 01/08/2009 | US20090012091 Oximide derivatives and their therapeutical application |
| 01/08/2009 | US20090012090 Radiohalogenated Benzamide Derivatives And Their Use In Tumor Diagnosis And Tumor Therapy |
| 01/08/2009 | US20090012086 Use of Non-Peptidic Nk1 Receptor Antagonists for the Production of Apoptosis in Tumor Cells |
| 01/08/2009 | US20090012085 Dosage forms and methods of treatment using a tyrosine kinase inhibitor |
| 01/08/2009 | US20090012084 7-Ethoxy-4-[(2-fluoro-4-methyl-phenyl)amino]-6-(4-methylpiperazin-1-yl)cinnoline-3-carboxamide, having colony stimulating factor 1 receptor (CSF-1R) kinase inhibitory activity, used as anticarcinogenic agents |
| 01/08/2009 | US20090012083 N-aroyl cyclic amine derivatives as orexin receptor antagonists |